World

Luigi Mangione pleads guilty in federal stalking case

Court hears he posed as investor to learn about UnitedHealthcare event, state murder trial still scheduled

Images

Luigi Mangione admits shooting healthcare CEO Brian Thompson and pleads guilty on federal charges – as it happened Luigi Mangione admits shooting healthcare CEO Brian Thompson and pleads guilty on federal charges – as it happened theguardian.com

Luigi Mangione pleaded guilty in Manhattan federal court to stalking charges tied to the 2024 killing of UnitedHealthcare chief executive Brian Thompson, according to The Guardian’s live reporting from outside the courthouse. Mangione admitted he shot Thompson in Manhattan, and Judge Margaret Garnett accepted the plea. The court set sentencing for 18 December, and Mangione remains in federal custody facing a possible life sentence.

The plea fills in the mechanics of how an attacker can reach a top corporate target even when an event is meant to be discreet. Mangione told the court he learned UnitedHealthcare would hold its annual investor convergence in December 2024, and that the location was not public. He then traveled to New York and emailed company leadership while posing as an institutional investor to get information about the gathering; UnitedHealthcare leadership replied within an hour, The Guardian reports, and Mangione researched who would attend.

The case also ties executive security to a wider set of vulnerabilities that do not sit neatly inside a firm’s physical perimeter. Mangione said he printed a gun using a 3‑D printer and attached a silencer, a combination that reduces reliance on traditional supply chains and makes advance interdiction harder. He acknowledged he understood his actions would place Thompson in fear of death or serious bodily injury, and that he knew the conduct was illegal—elements that federal prosecutors use to frame stalking as a distinct offense rather than a mere precursor to violence.

Legally, the guilty plea resolves only one of two cases. Mangione has pleaded not guilty in the separate state murder case, which is scheduled for trial next month, and his lawyers may seek dismissal on double-jeopardy grounds in light of the federal plea, according to The Guardian. That sequencing matters because it determines where evidence is aired first, which witnesses are compelled when, and which jurisdiction controls the timeline—details that can shape both public understanding and bargaining power even when no plea agreement exists.

In court, Mangione also described severe back pain and a broken back, and difficulties navigating the health system. Those claims sit alongside a meticulous approach to identifying a non-public corporate gathering and eliciting a rapid response from leadership.

Mangione entered the guilty plea at a hastily scheduled federal hearing. The state murder case is still set to begin next month.